Evidence map›Paper›PMID 38678161›Full record

ArticleEuropean journal of pediatrics2024

Neonatal herpes: case series in two obstetric centres over a 10-year period (2013-2023), France.

Elise Bouthry, Vincent Portet-Sulla, Melek Manai Bouokazi, Claire Périllaud-Dubois, François-Charles Javaugue, Laure Jule, Claire Boithias, Nolwenn Le Saché, Mostafa Mokhtari, Diane Carrière and 7 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Elise BouthryDepartment of Virology, Angers University Hospital, 4 rue Larrey, 49933, Angers, France. elise.bouthry@chu-angers.fr.
Vincent Portet-SullaGroupe de Recherche sur les Infections pendant la grossesse (GRIG), Paris, France.
Melek Manai BouokaziDivision of Virology, WHO Rubella National Reference Laboratory, Dept of Biology and Genetics, Paris Saclay University Hospital, APHP, Paris, France.
Claire Périllaud-DuboisGroupe de Recherche sur les Infections pendant la grossesse (GRIG), Paris, France.
François-Charles JavaugueDivision of Virology, WHO Rubella National Reference Laboratory, Dept of Biology and Genetics, Paris Saclay University Hospital, APHP, Paris, France.
Laure JuleDivision of Paediatric Critical Care and Neonatal Medicine, FAME Department, Paris Saclay University Hospital, "Kremlin-Bicetre" Medical Center-APHP, Paris, France.
Claire BoithiasDivision of Paediatric Critical Care and Neonatal Medicine, FAME Department, Paris Saclay University Hospital, "Kremlin-Bicetre" Medical Center-APHP, Paris, France.
Nolwenn Le SachéDivision of Paediatric Critical Care and Neonatal Medicine, FAME Department, Paris Saclay University Hospital, "Kremlin-Bicetre" Medical Center-APHP, Paris, France.
Mostafa MokhtariDivision of Paediatric Critical Care and Neonatal Medicine, FAME Department, Paris Saclay University Hospital, "Kremlin-Bicetre" Medical Center-APHP, Paris, France.
Diane CarrièreDivision of Paediatric Critical Care and Neonatal Medicine, FAME Department, Paris Saclay University Hospital, "Kremlin-Bicetre" Medical Center-APHP, Paris, France.
Louise SonnierDivision of Obstetrics and Gynecology, Centre Hospitalier Simone Veil, 41000, Blois, France.
Rafik BenammarDepartment of Neonatal Medicine, DMU2 Santé des Femmes et des Nouveau-nés, Paris Saclay University Hospital, "Antoine Béclère" Medical Center-APHP, Paris, France.
Alexandra LetourneauDivision of Obstetrics and Gynecology, DMU Santé des Femmes et des Nouveau-Nés, Paris Saclay University Hospital, "Antoine Béclère" Medical Center-APHP, Paris, France.
Alexandre J VivantiGroupe de Recherche sur les Infections pendant la grossesse (GRIG), Paris, France.
Anne-Gaël CordierDivision of Obstetrics and Gynecology, DMU Santé des Femmes et des Nouveau-Nés, Paris Saclay University Hospital, "Antoine Béclère" Medical Center-APHP, Paris, France.
Emmanuelle Letamendia-RichardDepartment of Neonatal Medicine, DMU2 Santé des Femmes et des Nouveau-nés, Paris Saclay University Hospital, "Antoine Béclère" Medical Center-APHP, Paris, France.
Christelle Vauloup-FellousGroupe de Recherche sur les Infections pendant la grossesse (GRIG), Paris, France.
Université Paris-Saclay · FRAssistance Publique – Hôpitaux de Paris · FRCentre de Recherche et de Documentation sur les Amériques · FRCentre Hospitalier Laennec · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonatal herpes simplex virus (HSV) infection (HSV infection in infants less than 6 weeks of age) is rare but mortality and morbidity rates are high after disseminated disease and encephalitis. In France, the epidemiology is poorly described, and two decades ago, incidence was estimated to be 3 per 100,000 live births a year. We describe determinants, epidemiologic and clinical characteristics of neonatal HSV infection in a managed-care population attending in two major obstetric and paediatric centres, Paris, France, over a 10-year period. This retrospective case series study was conducted from 2013 to 2023, in infants less than 42 days of age who had virologically confirmed HSV infection. We report an overall rate of neonatal herpes of 5.5 per 100,000 live births a year and an incidence of symptomatic cases of 1.2 per 100,000 live births a year. HSV-1 was the major serotype involved (84.2%) and post-natal acquisition through the orolabial route reached 63.2%. All neonates who had neonatal HSV PCR screening (owing to clinical signs in parents) and who received prompt acyclovir treatment remained asymptomatic. Symptomatic forms accounted for 21.1% cases of the total and mortality was high (62.5% of symptomatic forms).   Conclusion: This case series confirms that neonates at risk for HSV disease and poor outcome are those born to HSV-seronegative mothers, preterm infants, and those who received acyclovir after onset of symptoms (mainly because mothers did not present evidence of acute HSV infection). Our study confirms the major role of HSV-1 and the frequency of its early post-natal acquisition. What is known: • Neonatal herpes simplex virus infection is rare but motality and morbidity rates are high after disseminted disease and encephalitis. National recommendations exist worldwide but mangement of this disease is not always easy. What is new: • As in France epidemiology of neonatal herpes is poorly described, our report is potentially an important addition to the existing literature. Moreover, we describe local practice that may be useful to physicians.

Indexed as

Antiviral AgentsHerpes SimplexPregnancy Complications, InfectiousAcyclovirFemaleFranceHumansIncidenceInfantInfant, NewbornInfectious Disease Transmission, VerticalMaleParisPregnancyRetrospective StudiesAcyclovirAntiviral AgentsHerpes simplex virusIncidenceMaternal infectionNeonatal herpesPregnancy

Identifiers

PMID38678161
OpenAlexW4395689227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.